Peter M. O’Neill

Cellectis, New York, NY, United States

Articles by Peter M. O’Neill

A Digital Twin on CAR-T Cytokine Release Syndrome (CRS) Patients with Standard of Care Measured by CRS Distribution by Grade

ByGen Li, PhD, MBA,Jonathan Peachey,Paul Chew, MD,Peter M. O’Neill

May 26th 2023

Using existing clinical trial data to proactively model patient safety and efficacy outcomes could aid in accelerating development for areas in need of new therapies.

Peter M. O’Neill

Articles by Peter M. O’Neill

A Digital Twin on CAR-T Cytokine Release Syndrome (CRS) Patients with Standard of Care Measured by CRS Distribution by Grade

Latest Updated Articles

Trending on Applied Clinical Trials Online

The 10 Most Powerful Study KRIs in RBQM and GCP Issues They Can Prevent

Comparing OpenAI and Mistral on Clinical Trial Matching

What FDA Inspections Reveal About the Quality of APAC Clinical Trial Sites

Quotient Sciences first-in-human to proof-of-concept studies

ACT Brief: Capturing Trial Friction, AI Matching Model Comparisons, and Boehringer’s Oncology Deal